Enabling Clinical Trial Innovation Through AI Regulation at FDA
As the FDA stakes its claim as the primary regulator of AI in healthcare, it must navigate the delicate balance between fostering innovation and ensuring safety and responsibility.
Jess Ross
Dr. Jess Ross, PhD, serves as the Senior Governmental Affairs Lead at Unlearn.AI, a pioneering startup revolutionizing medicine through artificial intelligence. In this role, Dr. Ross champions the regulatory acceptance of AI-driven clinical trials through academic publications in the biostatistical and medical communities, as well as policy advocacy. She earned her PhD in Neuroscience from the University of Cincinnati/Cincinnati Children’s Hospital, where she received the 2017 Presidential Medal of Graduate Student Excellence for her advocacy, community contributions, and prolific scientific achievements. Following a postdoctoral fellowship in Stanford Medicine's Department of Anesthesia, Dr. Ross transitioned to medical writing for innovative startups. Her extensive expertise encompasses AI policy, biomedical science, biostatistics, and biotherapeutics, positioning her as a rising talent in the responsible integration of AI in medicine.